<DOC>
	<DOCNO>NCT02204280</DOCNO>
	<brief_summary>Definite diagnosis diabetic nephropathy currently base renal biopsy finding . In case , however , diagnosis reliably make patient macroalbuminuria presence diabetic retinopathy.Microalbuminuria often use prognostic marker type 1 diabetes , approximately 50 % type 1 diabetes patient microalbuminuria eventually develop diabetic nephropathy . Conversely , microalbu- minuria much less value marker DM variety cause , include hypertension . Thus , additional marker need identify patient group high risk develop overt diabetic nephropathy . The aim study check urine UbA52 level ELISA identify significance diagnosis diabetic nephropathy .</brief_summary>
	<brief_title>The Significance Urine UbA52 In Diagnosis Diabetic Nephropathy</brief_title>
	<detailed_description>It well recognize incidence diabetes increase worldwide . It lead cause end-stage renal disease ( ESRD ) Western country . Diabetic nephropathy report occur 25 % -40 % people diabetes . The appearance microalbuminuria usually regard incipient nephropathy , recently , work suggest individual diabetes decrease GFR may increase urinary AER.Identification marker prediction clinical course diabetic nephropathy remain major challenge . Previous research show m/z14766 protein mass spectrometry , selectively excreted urine diabetic nephropathy patient , m/z 14766 mass peak identify UbA52 . We suppose UbA52 regard simple practical biomarker diagnosis diabetic nephropathy .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>1. diabetes diagnostic criterion ( WHO , 1999 ) , age &lt; 80 year old , gender limit ; 2. diabetic macroor microalbuminuria ; 3. subject take hemodialysis ; 4. proteinuria due nondiabetic renal disease : Hypertensive renal damage , druginduced acute interstitial nephritis , IgA , primary membranous nephropathy , FSGS MCD , confirm renal biopsy . 1. acute diabetic complication : ketoacidosis , hypertonic coma ; 2. diagnosis malignant tumor , particularly affect liver kidney function tumor application radiation chemotherapy treatment patient ; 3. cardiac insufficiency , heart function class 3 ; 4. data complete , impact result ; 5. hospitalize patient ; 6. accept longterm oral static point method steroid hormone therapy , application renal toxicity drug ; 7. exception primary kidney disease cause lead eye disease ; 8. combination respiratory system infection systemic diseases patient severe primary disease , vigorous exercise within 24 hour ; 9. pregnancy breastfeed woman 10. clear liver disease , alanine aspertate aminotransferase 2 time higher normal limit ; 11. reluctant collaborator psychiatric patient ; 12. undergoing hemodialysis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>UbA52 ; diabetic nephropathy ; diabetic ; ELISA</keyword>
</DOC>